TCM
JBIO
TCG Crossover Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $640K | Sell |
64,023
-2,176,786
| -97% | -$21.7M | 0.07% | 36 |
|
|
2025
Q1 | $5.62M | Hold |
2,240,809
| – | – | 0.77% | 30 |
|
|
2024
Q4 | $5.94M | Hold |
2,240,809
| – | – | 0.58% | 34 |
|
|
2024
Q3 | $4.68M | Hold |
2,240,809
| – | – | 0.4% | 31 |
|
|
2024
Q2 | $3.72M | Buy |
2,240,809
+39,535
| +2% | +$65.6K | 0.39% | 28 |
|
|
2024
Q1 | $65.1M | Hold |
2,201,274
| – | – | 5.15% | 6 |
|
|
2023
Q4 | $49.8M | Hold |
2,201,274
| – | – | 5.52% | 6 |
|
|
2023
Q3 | $29.9M | Hold |
2,201,274
| – | – | 4.4% | 9 |
|
|
2023
Q2 | $37.8M | Buy |
2,201,274
+1,120,000
| +104% | +$19.2M | 6.19% | 5 |
|
|
2023
Q1 | $21.8M | Hold |
1,081,274
| – | – | 4.25% | 10 |
|
|
2022
Q4 | $31.7M | Buy |
1,081,274
+121,702
| +13% | +$3.57M | 5.59% | 7 |
|
|
2022
Q3 | $15.9M | Buy |
959,572
+70,000
| +8% | +$1.16M | 4.77% | 9 |
|
|
2022
Q2 | $13.9M | Hold |
889,572
| – | – | 5.91% | 9 |
|
|
2022
Q1 | $16.3M | Buy |
889,572
+36,242
| +4% | +$664K | 6.55% | 7 |
|
|
2021
Q4 | $10.1M | Buy |
+853,330
| New | +$10.1M | 4.71% | 10 |
|